Innovation in healthcare: opportunity + capability

Inbio ventures

Latest news

Our Portfolio Company, Jounce Therapeutics, Signed a Major Collaboration Deal with Celgene to Develop Next-Generation Immuno-oncology Therapies

read more →

Pharmstandard International S.A. Represented by Inbio Ventures Participated in Growth Financing of TransMedics, Inc. from a Strong Investor Syndicate to Transform Organ Transplant Therapy

read more →

Pharmstandard International, S.A., leads the new financing of up to $60 Million in Argos Therapeutics

read more →